Table 3.
Study ID | Events* | Total number of participants | % |
Porres 1989 | 0 | 10 | 0 |
Rosina 1989 | 0 | 12 | 0 |
Rosina 1991 | 16 | 31 | 51.6 |
Farci 1994 | 2 | 28 | 7.1 |
Gaudin 1995 | 4 | 11 | 36.4 |
Madejon 1994 | 7 | 32 | 21.9 |
Total | 29 | 124 | 23.4 |
Total number of participants are the patients who received interferon. Events represent number of participants experiencing adverse events requiring dose modification or termination of therapy